About Index Trending news
Lists
Pricing
The Column Group

The Column Group

Elsewhere

Alexa global traffic share

Investment profile

Geographical Focus
United States
Markets focus
Biotechnology
Stage Focus

Activity

Past year's investments
  • 5 rounds in the past year
  • $158,800,000 deployed in total
  • $31,760,000 avg per round
Latest rounds
  • Exonics Therapeutics: Venture capital (Series A) ($40M)
  • Effector Therapeutics: Venture capital (Series C) ($38.6M)
  • Peloton Therapeutics: Undisclosed funding ($22.2M)
Total funding
$187.2M in 5 rounds from 16 investors
By The Column Group
$55M Venture Capital in Dec, 2015
Total funding
$295.4M in 5 rounds from 13 investors
By The Column Group
$26.6M Series A in Dec, 2009
Total funding
$142.4M in 3 rounds from 15 investors
By The Column Group
$52.4M Series D in Sep, 2016
Total funding
$83.6M in 2 rounds from 19 investors
By The Column Group
$38.6M Series C in Jul, 2017
Total funding
$53.2M in 2 rounds from 4 investors
By The Column Group
$38M Series B in Dec, 2014
Exit Bristol-Myers Squibb, Feb 23, 2015
Total funding
$99M in 4 rounds from 15 investors
By The Column Group
$49M Series C in Oct, 2013
Total funding
$50M in 1 rounds from 4 investors
By The Column Group
$50M Series B in Apr, 2016
Total funding
$70M in 1 rounds from 9 investors
By The Column Group
$70M Series B in Sep, 2016
Total funding
$92.6M in 4 rounds from 10 investors
By The Column Group
$22.2M Undisclosed funding in Mar, 2017
Total funding
$70M in 2 rounds from 3 investors
By The Column Group
$25M Series A in Dec, 2016
Total funding
$50M in 1 rounds from 1 investors
By The Column Group
$50M Series A in Dec, 2016
Total funding
$45M in 2 rounds from 2 investors
By The Column Group
$40M Series A in Nov, 2017
Total funding
$33M in 1 rounds from 1 investors
By The Column Group
$33M Series A in Feb, 2017

Want to see the complete list?
Go Pro!